Dose-dependent elimination kinetics of theophylline
- PMID: 519931
- DOI: 10.2165/00003088-197904060-00004
Dose-dependent elimination kinetics of theophylline
Abstract
There are an increasing number of clinical and experimental studies appearing in the literature suggesting that the elimination kinetics of theophylline may be dose-dependent in man. Evidence of nonlinearity includes observations that steady-state serum theophylline concentrations may increase disproportionately with increases in dose and that the elimination half-life of theophylline after multiple doses is longer than after single doses. Theophylline is apparently eliminated by parallel Michaelis-Menten and first-order kinetics. Although no specific studies of theophylline metabolism have been carried out to determine the causes of nonlinearity, it would appear that 1-demethylation of theophylline is a potentially saturable metabolic pathway. Dietary methylxanthines or their metabolites may influence the rate of elimination of theophylline and contribute to the causes of nonlinearity. Until the elimination kinetics of theophylline have been studied in more detail as a function of dose, it would seem prudent to increase doses of theophylline cautiously to minimise the risks of adverse side effects which might be associated with unexpected accumulation of theophylline.
Similar articles
-
Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.Clin Pharmacokinet. 1985 Sep-Oct;10(5):432-42. doi: 10.2165/00003088-198510050-00005. Clin Pharmacokinet. 1985. PMID: 3899457 Review.
-
Dose-dependent elimination of theophylline in rats.Xenobiotica. 1985 Feb;15(2):165-71. doi: 10.3109/00498258509045346. Xenobiotica. 1985. PMID: 4002738
-
Dose-dependent kinetics of theophylline.J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):723-7. doi: 10.1016/0091-6749(86)90052-7. J Allergy Clin Immunol. 1986. PMID: 3534053 Review.
-
Nonlinear theophylline elimination.Clin Pharmacol Ther. 1982 Mar;31(3):358-69. doi: 10.1038/clpt.1982.46. Clin Pharmacol Ther. 1982. PMID: 7060318
-
Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.Eur J Drug Metab Pharmacokinet. 2001 Jan-Jun;26(1-2):77-83. doi: 10.1007/BF03190380. Eur J Drug Metab Pharmacokinet. 2001. PMID: 11554438 Clinical Trial.
Cited by
-
Comparison of single and multiple dose pharmacokinetics of theophylline using stable isotopes.Eur J Clin Pharmacol. 1986;30(1):113-20. doi: 10.1007/BF00614207. Eur J Clin Pharmacol. 1986. PMID: 3709624
-
The interaction of erythromycin with theophylline.Eur J Clin Pharmacol. 1987;32(5):493-8. doi: 10.1007/BF00637676. Eur J Clin Pharmacol. 1987. PMID: 3622597
-
Dose-dependent pharmacokinetics with single daily dose slow release theophylline in patients with chronic lung disease.Br J Clin Pharmacol. 1982 Feb;13(2):241-3. doi: 10.1111/j.1365-2125.1982.tb01368.x. Br J Clin Pharmacol. 1982. PMID: 7059426 Free PMC article. No abstract available.
-
Saliva theophylline concentrations after a single oral dose.Br J Clin Pharmacol. 1982 Feb;13(2):243-5. doi: 10.1111/j.1365-2125.1982.tb01369.x. Br J Clin Pharmacol. 1982. PMID: 7059427 Free PMC article. No abstract available.
-
Influence of chronic dosing on theophylline clearance.Br J Clin Pharmacol. 1984 May;17(5):525-30. doi: 10.1111/j.1365-2125.1984.tb02385.x. Br J Clin Pharmacol. 1984. PMID: 6733000 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources